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ABSTRACT Rats were raised after weaning on a vitamin D-
deficient diet which used whole wheat and casein as the major
protein source. For at least the first year of life, plasma calcium
concentrations of these rats were the same as those of vitamin D-
replete rats, and the rate of growth was normal for at least 6
months. The following evidence establishes the vitamin D defi-
ciency of the rats (both male and female) on this diet: (i) plasma
levels of 1,25-dihydroxycholecalciferol (1,25-dihydroxyvitamin D3)
became undetectable after 6 weeks on the diet; (ii) by 4 months
of age, the epiphyseal growth plates of the tibia were significantly
enlarged and disorganized; (iii) when subjected to fracture in a
dynamic torsion machine, the femur showed marked weakening
as indicated by stress analysis; (iv) isolated kidney cells from the
deficient rats showed a 3-fold increase in 25-hydroxyvitamin D 1-
hydroxylase activity. When mother rats were placed on the vita-
min D-deficient diet during lactation, plasma calcium values in the
pups decreased and remained low throughout life and there was
a stunted body growth pattern. It is concluded that hypocalcemia
is not a necessary manifestation of vitamin D deficiency, that the
onset of vitamin D deficiency during neonatal life influences the
calcium homeostatic system, and that the normocalcemic, vitamin
D-deficient animal provides an experimental model in which the
effects of vitamin D deficiency can be studied independently of
hypocalcemia.
Prior to the availability of reliable assays for 1,25-dihydroxy-
cholecalciferol [1,25-dihydroxyvitamin D3; 1,25-(OH)2D3], a
deficiency in this vitamin in chicks and rats was identified by
measuring the decrease in plasma calcium and phosphorus con-
centrations that resulted in time from the use of classical rach-
itogenic diets (1, 2). Various dietary manipulations such as the
addition to the diet of large quantities of glucose (3) or manip-
ulation of the calcium-to-phosphorus ratio (4) were usually used
to give the desired end result-i.e., a low plasma calcium con-
centration, thereby indicating a deficiency of 1,25-(OH)2D3.
The rat chow routinely provided animals to be used in all
experiments by our research groups is that developed by Tov-
erud and associates (5). This diet includes ground whole wheat
and casein as protein sources with a total phosphorus content
of0.4% in the form oforganic phosphate. Normally, the calcium
content is also 0.4% but can be varied from near zero to 1%.
Recent studies in our laboratories required that both male and
female rats be maintained for up to 1 year on a vitamin D-de-
ficient diet. Therefore, the same diet, without vitamin D, was
used. Data presented here provide evidence for the disasso-
ciation of hypocalcemia from vitamin D deficiency.
MATERIALS AND METHODS
Reagents. Collagenase and hyaluronidase for tissue digestion
were obtained from Sigma. Salt solutions and media were ob-
Table 1. Contents of diet provided experimental rats*
Component Amount, % (wt/wt)
Whole wheat flour 75
Casein (vitamin-free) 15
Corn oil 4






Modified from Boass et al. (5).
tFor vitamin D-deficient diet, vitamin mix was void of vitamin D.
t Includes phosphorus contained in whole wheat.
§ Calcium content controlled by use of CaCO3.
tained from GIBCO. 25-OH[26,27-methyl-3H]D3 (9 Ci/mmol;
1 Ci = 3.7 x 1010 becquerels) was purchased from Amersham.
25-OHD3 was a gift from Upjohn. Other D3 metabolites-24,25-
(OH)2D3, 25,26-(OH)2D3, 1,25-(OH)2D3, and 1,24,25-
(OH)3D3--were gifts from M. Uskokovic (Hoffmann-LaRoche).
All organic solvents used were the grade required for HPLC.
Rat diets were prepared for us by ICN Biochemicals.
Animals. Sprague-Dawley (ARS Laboratories, Madison, WI)
rats were maintained under standardized conditions of tem-
perature, humidity, and light. The female rats were fed ad lib.
In the major experiment utilizing males, the rats were trained
to a 0900 feeding schedule and were fed 16-18 g daily. Rats were
obtained either as 10-day-old litters (with mothers) or were pur-
chased to be shipped after weaning on the 21st-23rd days of life.
Rats to be made vitamin D deficient were fed our vitamin D-
deficient diet (Table 1) between days 23 and 25 and maintained
on this diet thereafter. Both deficient rats and their vitamin D-
replete controls were maintained in a room illuminated with
filtered fluorescent lighting.
At specified intervals after initiation of the vitamin D-defi-
cient regimen, blood samples were obtained for serum calcium
and phosphorus analysis (6, 7). For the first 6 weeks, sufficient
numbers of rats were sacrificed to provide plasma for 1,25-
(OH)2D3 determination. At later times, blood for metabolite
analysis was obtained when animals were sacrificed. 1,25-
(OH)2D3 levels were quantitated by radioimmunoassay after
HPLC separation from other metabolites (8).
Biomechanics. Rat femurs were tested in a dynamic torsion-
testing machine with a dual beam oscilloscope attachment. The
two ends of each femur were cast in a quick-setting polyester
resin in a mold that fitted into the torsion-testing machine. The
distance between these two mold end pieces was kept constant
so that the length ofthe femur exposed to fracture was also con-
stant. One end of the bone specimen was rigidly held in place;
Abbreviation: D3, cholecalciferol (vitamin D3).
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the opposite end was subjected to a sudden twist. The torque
applied and the resultant angular displacement of the bone
ends were continuously recorded on the oscilloscope. These
torque-angle relationships were calculated from Polaroid
camera film copies of the oscilloscope tracings.
Four parameters ofbone strength were calculated according
to Panjabi et al. (9). The torque was measured as the y coor-
dinate of the curve at the highest point in the peak. The angular
displacement was the x coordinate. The mean torsional rigidity
was calculated as the ratio of torque to angular displacement at
the point of fracture. The elastic energy absorption to fracture
was calculated as one-half the torque times angular displacement.
Histology of Bone. Tibia were removed immediately upon
sacrifice of the animal and dissected free of soft tissue. A piece
ofcortical bone was removed transversely from the anterior tub-
erosity of the proximal tibia to allow for quicker penetration of
the fixatives. Bones were then placed in a phosphate-buffered
modified Millonig's fixative at pH 7.4 and 370C. Samples were
dehydrated with increasing concentrations of acetone and
embedded in methyl methacrylate. Undecalcified bone sec-
tions were cut at a thickness of 5 Am on a Jung model K mi-
crotome, collected on 0.5% calfskin gelatin-coated slides, and
stained with a modified Goldner stain.
Light microscopic evaluations were made with a Leitz mi-
croscope on coded slides. For each animal, 50 measurements
of the growth plate width were made with x 16 objective and
x 12.5 eyepiece. Growth plate width in the rat tibia is defined
as beginning at the zone of reserve cartilage and passing toward
the ossification center. This area consists of the resting zone,
zone of cellular proliferation, zone of matrix synthesis, zone of
hypertrophy, and initial location of provisional calcification.
Isolation of Renal Cells. At the time of sacrifice, cells were
obtained from the kidneys of deficient and replete rats for in
vitro metabolism studies. The cells were isolated according to
a modification of the procedure of Turner et al. (10). Kidneys
were perfused in situ with calcium-free salt solution to remove
blood and subsequently with 100 ml of a calcium-containing
magnesium-free solution of collagenase (0.5%). At this point,
kidneys were removed from the animal, dissected free of cap-
sule, and minced into flasks containing 1.0% collagenase and
2% hyaluronidase for a 15-mmn incubation at 370C. After me-
chanical dispersion, the cells were washed three times with a
calcium-free salt solution and resuspended in calcium-contain-
ing medium (McCoy's 5a) at a concentration of 5 X 10' cells per
ml.
Metabolism of 25-OH[3H]D3. Flasks containing isolated
renal cells and tubules were gassed with 95% 02/5% C02 for
60 sec and incubated at 370C with 25-OH[3H]D3 at varying con-
centrations in a shaking incubator for 1 hr. At the end of the
incubations, the flasks were quick frozen in dry ice/ethanol and
stored for later extraction and chromatography as described
(11). Protein content per flask was determined by the procedure
ofLowry et al. (12).
RESULTS
Growth and Metabolite Levels. By the time the vitamin D-
deficient rats were 3 months old, their plasma 1,25-(OH)2D3
levels were nondetectable (<6 pg/tube). Table 2 shows a com-
parison of serum calcium and 1,25-(OH)2D3 levels at several
times. The calcium values did not decrease despite the gradual
decline in 1,25-(OH)2D3. At the time of sacrifice, 1,25-(OH)2D3
levels were nondetectable even when 10 ml of serum was ex-
tracted.l Serum calcium levels were not significantly different
from those of rats raised on an identical diet containing vitamin
D3. Serum phosphate levels, determined in several experi-
Table 2. Circulating 1,25-(OH)2D3 in serum of rats on vitamin
1)-deficient diet since weaning








ments, were not significantly different (mean ± SEM: replete,
6.5 ± 0.05 mg/dl; deficient, 6.2 ± 0.2 mg/dl). There was no
difference in body weights of these two groups at least up to 6
months of age.
Biomechanics. Upon sacrifice, it was noted that the deficient
animals had shorter femurs than the replete rats. Precise length
and geometric shapes of these bones were not measured at that
time. The results of the biomechanical torsion testing are listed
in Table 3. Calculated values of fracture torque and torsional
rigidity were significantly decreased in the deficient animals.
These properties are dependent upon the geometrical structure
of the bone. Therefore, these measurements do not reflect di-
rectly the quality of bone but are related more to the gross
properties of the femur. The torsional rigidity measurements
indicate that the femurs from the replete rats had more resis-
tance to deformation than did those from the deficient rats. The
latter femurs were weaker-less torque was required to fracture
the bone. The amount of energy absorbed prior to the fracture
of the femur was almost 50% less in the deficient animals. How-
ever, due to the small number of vitamin D-deficient bones
prepared for this study, the statistical significance of this dif-
ference was marginal.
These biomechanical studies indicate that there is a signifi-
cant difference in the properties of bone from replete and de-
ficient animals. This difference may be due to the size and shape
of the bone, to its internal and external geometric structure, or
to its intrinsic mechanical properties.
Histology of Bone. Vitamin D-replete and vitamin D-defi-
cient rats were sacrificed at 5 months old. Gross examination
of the bone revealed that, in the deficient rats, the tibias were
extensively bent and the femurs were shortened. More precise
measurements of bone length were not made at this time. The
epiphyseal growth plate of the tibia appeared to be wider in the
deficient rats compared to the replete rats (mean ± SD: replete,
181.13 ± 17.71 A.m3, n = 3; deficient, 296.59 ± 33.80, n = 3;
P < 0.05). Histological examination of the tibia confirmed the
presence of an enlarged epiphyseal growth plate with extremely
irregular boundaries. Also, the various zones of cellular activity
in the growth plate were not as distinct as those seen in the
replete rats. There was also an increase in the number of chon-
drocytes in the zone ofcellular hypertrophy in the deficient rats
(Fig. 1).
Table 3. Biomechanical data from vitamin 1)-replete and
vitamin 1)-deficient rats
With vitamin 1) Without vitamin 1)
Measurement (n = 23) (n =8)
Fracture torque, Nm 0.62 ± 0.05 0.38 ±0.09*
Angular displacement, 0 8.71 ± 0.86 8.10 ±1.40
Torsional rigidity, Nm/0 2.21 ± 0.19 1.17 ±0.26*
Fracture energy, Nm 333.6 ± 45.6 171.6 ±64.7
Results are shown as mean ± SD.'*For difference between regimens, P < 0.025.
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FIG. 1. Histological changes in the epiphyseal area of nondecalcified tibia from vitamin D-replete (A and C) and vitamin D-deficient (B and
D) rats. Tibia from replete animals demonstrate a smooth line of cartilaginous growth plate (arrows) and chondrocytes (C) arranged.in columns
parallel to the bone axis. Tibia from deficient animals show an irregular growth plate line (arrows) and disorderly alignment of chondrocytes (C).
(A and B, x 11; C and D, x 44.)
In Vitro Metabolism of 25-OHD3. Cells from the kidneys of
vitamin D-deficient rats converted 25-OH[3H]D3 predomi-
nantly to 1,25-(OH)2[3H]D3, whereas cells from kidneys of re-
plete rats converted 25-OH[3H]D3 to other metabolites mi-
grating in the region of24,25-(OH)2D3, 25,26-(OH)2.D3, and the
25(OH)D3 26,23-lactone with only slight formation of 1,25-
(OH)2[3H]D3. Formation of dihydroxylated metabolites in-
creased (Table 4) in both groups as substrate level (25-OH[3H]
D3) increased. Differences in 1,25-(OH)2[3H]D3 formed by cells
from the replete and deficient.rats were significant.at all three
substrate levels.
: DISCUSSION
The first problem was to establish that the rats used were indeed
vitamin D deficient. By vitamin D deficiency, we mean that
there was insufficient 1;25-(OH)2D3 circulating within the an-
imal to maintain normal bone morphology. To detect the pos-
sibility that this metabolite might still be circulating in small
quantities, we extracted 10 ml of plasma obtained from rats on
our deficient diet for 3 months and found no detectable 1,25-
(OH)2D3. Our data demonstrate a gradual disappearance of
1,25-(OH)2D3 from the circulation, becoming undetectable be-
tween 6 and 10 weeks after. start of the dietary regimen. Mallon
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Table 4. In vitro 25-OHD 1-hydroxylase activity in renal cells
isolated from vitamin D-replete and vitamin D-deficient rats
Hydroxylase activity,* fmol/min/mg protein.
50 nM 100 nM 300 nM
25-OHD3 25-OHD3 25-OHD3
Control, vitamin D
replete 1.89 ± 0.12 3.37 ± 0.52 15.55 ± 1.81
Vitamin D deprived,
normocalcemic 5.20 ± 0.43 13.63 ± 2.21 46.53 ± 3.38
* Mean ± SD.
et aL reported a similar pattern of decline in serum 1,25-
(OH)2D3 levels in rats eating a diet containing 1% calcium and
0.7% phosphorus (13).
The major metabolite formed in vivo upon administration of
25-OHD3 was 1,25-(OH)2D3. Renal cells isolated~from our nor-
mal calcemic, vitamin D-deficient rats converted 25-OH[3H]D3
to 1,25-(OH)2[3H]D3 at a rate 2-3 times that observed in cells
from vitamin D-replete rats. This acceleration of 25-OHD 1-
hydroxylase activity is a further indication of the absence of vi-
tamin D in these rats. This model allows one to measure en,
hanced 25-OHD 1-hydroxylase activity without the added effect
of hypocalcemia.
Morphological data provided a further indication of vitamin
D deficiency. The epiphyseal growth plate of the tibia was en-
larged by month 4 of the regimen. In addition, the typical dis-
arrangement of the columns of cartilage cells was readily ap-
parent. At the present time, we are not able to confirm or
dispute the report of Howard and Baylink (14) that increase of
plasma calcium in vitamin D-deficient rats by use of a 1.2%
calcium diet with added lactose returns the appearance of this
area of the metaphysis to near normal.
By month 4 on the vitamin D-deficient diet, bones from our
deficient rats were weaker than bones from the replete rats.
Because all of the rats were fed 16 g offood daily and consumed
their allowance, we can consider our data to represent pair-fed
experiments. Under these conditions, body weight gain in de-
ficient rats was not significantly less than in replete rats, at least
for 6 months.
The significant question is why the plasma calcium values
remained normal in the rats deprived of vitamin D when they
decrease in most other models used for vitamin D deficiency.
One component absent from our diet which is usually present
in vitamin D-deficient diets is glucose. It has never been clear
why many rachitogenic diets for both chicks and rodents contain
high percentages of glucose. One might speculate that glucose
could either alter intestinal absorption ofcalcium or act directly
upon the 25-(OH)D 1-hydroxylase system to increase the rate
at which 1,25-(OH)2D3 and serum calcium decrease. To our
knowledge, neither concept has been tested.
An alternate explanation relates to the time when the rats
were placed on the vitamin D-deficient diet. We can produce
a hypocalcemic vitamin D-deficient rat if the lactating mother
is transferred to the deficient diet. When weaned to the same
diet, pups from these mothers are unable to maintain normal
serum calcium levels and show a permanent stunting of body
growth. It appears that maternal deprivation of vitamin D dur-
ing lactation produced permanent damage to those bone pro-
cesses controlling calcium homeostasis in the offspring.
It has been reported that vitamin D-deficient rats with low
plasma calcium concentrations are unable to respond to para-
thyroid hormone (15). This would be the case if there were per-
manent damage to bone processes. Our normocalcemic vitamin
D-deficient rats were responsive to both parathyroid hormone
and calcitonin during the first 6 months on this diet (unpub-
lished data).
Finally, the advantages of this model in the study of vitamin
D deficiency are related to two aspects: (i) it separates the effects
of vitamin D deficiency from those of prolonged hypocalcemia;
and (ii) it provides an, animal model in which the progressive
effects of vitamin D deficiency are more similar to the devel-
opment ofosteomalaciain the adult human. Investigators using
this model, can no longer depend on the decrease in plasma cal-
cium values as an indicator of vitamin D deficiency. Assays for
1,25-(OH)2D3 or identification of bone abnormalities will be
needed to define vitamin D deficiency.
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